Part 3 — Jacques Tremblay — International Seminar on Pharmaceutical Sciences — CRISPR Method
To clearly understand the clinical aspects involved in Part 3 This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Part 3 — Jacques Tremblay — International Seminar on Pharmaceutical Sciences — CRISPR Method" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.
Complementary Audiovisual Content: Click here to watch the full explanatory video on the official Brasil Sem Alergia YouTube channel..
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Applications of CRISPR-Cas9 Technology in the Treatment of Genetic Diseases and Neuromuscular Disorders
The CRISPR-Cas9 gene-editing technology, originally discovered from the immune defense system of bacteria against bacteriophages, has revolutionized biomedical research and the development of innovative therapies. The mechanism involves the use of guide RNA sequences associated with the Cas9 protein, which act as precision molecular tools capable of locating specific sequences in the human genome and inducing targeted cuts in DNA. This technology has enabled significant advances in the investigation and potential management of various complex hereditary conditions.
Mechanisms of Action and Strategies of Genomic Repair
When the CRISPR-Cas9 complex promotes double-strand DNA breaks at a precisely determined genomic site, the cell triggers its natural repair mechanisms. These processes occur primarily through two distinct pathways:
- Non-Homologous End Junction (NHEJ): A mechanism that frequently generates microdeletions or microinsertions, widely used to inactivate the expression of specific genes (a process known as knockout).
- Homologation-Driven Repair (HDR): A process that requires the presence of a donor DNA molecule, allowing the replacement of mutated sequences with healthy copies or the insertion of new gene segments.
Despite its high versatility, one of the main technical challenges associated with the use of the technology is the occurrence of off-target mutations (off-target), in which cuts can be induced in unintended regions of the genome. To mitigate this risk and increase accuracy, researchers have developed modified variants of the Cas9 enzyme—such as nickases—and optimized the design of guide RNAs.
Therapeutic Applications in Hereditary Diseases and Dystrophies
The versatility of the CRISPR system has enabled the development of experimental therapeutic approaches for serious genetic diseases, most notably Friedreich's ataxia and Duchenne muscular dystrophy (DMD).
In Friedreich's ataxia, the condition is often caused by a trinucleotide repeat (GAA) expansion in the first intron of the frataxin gene, which drastically reduces protein expression. The use of CRISPR-Cas9 allows for the removal of this anomalous repeat, significantly restoring cellular frataxin levels. Similarly, in the context of Duchenne muscular dystrophy—characterized by mutations in the dystrophin gene—innovative strategies seek to create functional hybrid exons or restore the protein reading frame directly at the DNA level, offering prospects for permanent treatments compared to traditional therapies based solely on messenger RNA.
Recent Innovations: Base Edition and Prime Edition
The continuous evolution of technology has resulted in even more refined tools, such as database editing (base editing) and the prime edition (prime editingBase editing allows for the direct conversion of individual nucleotides—such as the transformation of cytosine into thymine—which shows great promise in correcting point mutations associated with neurodegenerative diseases, such as Alzheimer's disease. In turn, prime editing uses a modified Cas9 based on a reverse transcriptase and guided by a specialized RNA (pegRNA), allowing the replacement, insertion, or deletion of small stretches of DNA with extraordinary versatility and precision.
Note: This text is strictly educational and informative in nature and should in no way replace medical consultation, diagnosis, or individualized assessment with a specialist physician.
Developments in Evidence-Based Medicine: Pathophysiological Correlation and Clinical Management
Under the principles of Evidence-Based Medicine (EBM) In the context of Allergy and Clinical Immunology, the interpretation of respiratory, cutaneous, gastrointestinal, or systemic signs and symptoms requires rigorous correlation between the... detailed clinical history (phenotype) and the underlying immunological mechanisms (endotype — mediated by IgE, T lymphocytes, immune complexes, or innate immunity pathways). Targeted diagnostic investigation — using standardized skin tests, specific laboratory assays, and functional tests — allows for precise differential diagnosis, avoidance of self-medication, and the establishment of an individualized therapeutic plan aimed at sustained control of inflammation and preservation of the patient's quality of life.
💎 Diamond Plan — Precision medicine is already part of modern allergy care. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Integrated Approach in Allergy and Clinical Immunology: Diagnosis and Prevention
Understanding Immune Hypersensitivity and Its Modifiable Factors
Allergic and immune-mediated manifestations result from the dynamic interaction between genetic inheritance, epithelial barriers (respiratory, cutaneous, and digestive), and continuous exposure to everyday environmental factors. Unlike self-limiting infectious conditions, hypersensitivity processes tend to recur when only superficial symptoms are treated palliatively, making it essential to understand the underlying immunological mechanism—whether mediated by IgE antibodies, T cells, or mixed inflammatory pathways.
Specialized Investigation, Allergy Testing and Immunotherapy
The safest path to regaining well-being begins with a detailed medical history combined with... allergy test appropriate to each clinical suspicion. With the etiological diagnosis established, modern strategies such as allergy vaccine and the rhinitis treatment Treatment of related respiratory or skin conditions allows for controlling underlying inflammation, reducing the repetitive use of symptomatic medications, and promoting lasting quality of life.
Importance of Differential Diagnosis and Detailed Medical History
In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving Part 3 may present with completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of flare-ups, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable guide for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond the direct physical manifestations, uncontrolled conditions linked to Part 3 profoundly interfere with the architecture of restorative sleep, the ability to concentrate at school and at work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being of the individual.
Frequently Asked Questions in Clinical Practice
Immunological Reactions to Insect Bites and Prevention of Crises: Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.
Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management: The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis: Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.
Skin Barrier Health, Immune Inflammation, and Pruritus Control: In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.
Immunology of Cutaneous Autoimmune Diseases and Integrated Care: Unlike purely IgE-mediated dermatoses, psoriasis and related autoimmune conditions involve the activation of plasmacytoid dendritic cells, interferon-gamma production, and sustained stimulation of the interleukin-23/interleukin-17 (IL-23/IL-17) and TNF-alpha axis. This signaling accelerates the epidermal keratinocyte renewal cycle several times over, resulting in well-defined erythematous-desquamative plaques and, in some patients, associated joint inflammation. Infections, mechanical or chemical trauma to the skin (Koebner phenomenon), dry winter weather, and emotional stress act as important amplifiers of the inflammatory response.
Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management: When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.
Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling: Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.
Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity: Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Pharmacological Safety, Adverse Drug Reactions, and Rational Use of Corticosteroids: Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.
Safe Immunization, Immune Response, and Protection of the Allergic Patient: In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.
Precision Medicine: How Monoclonal Antibodies and Immunobiologics Work: Monoclonal antibodies (immunobiologics) have revolutionized the management of severe allergic and immune-mediated diseases that do not achieve full control with conventional therapies. Unlike systemic corticosteroids and classic immunosuppressants—which broadly depress immunity and generate metabolic toxicity—immunobiologics act as highly precise molecular keys, neutralizing specific targets of the inflammatory cascade: such as circulating free IgE (omalizumab), the IL-4 and IL-13 receptor (dupilumab), the eosinophilic pathway of IL-5 (mepolizumab and benralizumab), or the epithelial alarmin TSLP (tezepelumab).
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Precision medicine is already part of modern allergy care.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Part 3 It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




